Response from the Original Author: Author's Reply to Walter and Guyatt

Therapeutic Innovation & Regulatory Science

Volumn 37, Issue 1, 2003, Pages 7-10

  Senn, Stephen ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84996259197     PISSN: 21684790     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150303700103     Document Type: Article

References (14)

1. Senn SJ Individual therapy: New dawn or false dawn. Drug Inf J. 2001; 35: 1479–1494.
2. Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS Interpreting treatment effects in randomised trials [see comments]. Br Med J. 1998; 316: 690–693.
3. Senn SJ Statistical Issues in Drug Development. Chichester, United Kingdom: John Wiley; 1997.
4. Senn SJ Applying results of randomised trials to patients. N of 1 trials are needed [letter; comment]. Br Med J. 1998; 317: 537–538.
5. Shumaker RC, Metzler CM The phenytoin trial is a case study of “individual bioequivalence.” Drug Inf J. 1998; 32: 1063–1072.
6. Anderson S, Hauck WW Consideration of individual bioequivalence. J Pharmacokinetics Biopharmaceutics. 1990; 18: 259–273.
7. Senn SJ Statistical quality in analysing clinical trials. Good Clin Practice J. 2000; 7: 22–26.
8. Senn SJ Authorship of drug industry trials. Pharmaceutical Stat. 2002; 1: 5–7.
9. Guyatt G, Juniper EF, Goldstein BJ Author's reply. Br Med J. 1998; 317: 537.
10. Senn SJ Cross-over Trials in Clinical Research. Chichester, United Kingdom: John Wiley; 2002.
11. Walter SD Number needed to treat (NNT): Estimation of a measure of clinical benefit. Stat Med. 2001; 20: 3947–3962.
12. Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A. Quality of life in asthma clinical trials: Comparison of salmeterol and salbutamol. Am J Respir Crit Care Med. 1995; 151: 66–70.
13. Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE Measuring quality of life in asthma. Am Rev Respir Dis. 1993; 147: 832–838.
14. Horwitz RI, Singer BH, Makuch RW, Viscoli CM Can treatment that is helpful on average be harmful to some patients? A study of the conflicting information needs of clinical inquiry and drug regulation [see comments]. J Clin Epidemiol. 1996; 49: 395–400.